Hemocompatibility-Related Adverse Events and Survival on Venoarterial Extracorporeal Life Support: An ELSO Registry Analysis.

MLA

Chung, Mabel, et al. “Hemocompatibility-Related Adverse Events and Survival on Venoarterial Extracorporeal Life Support: An ELSO Registry Analysis.” JACC. Heart Failure, vol. 8, no. 11, Nov. 2020, pp. 892–902. EBSCOhost, https://doi.org/10.1016/j.jchf.2020.09.004.

APA

Chung, M., Cabezas, F. R., Nunez, J. I., Kennedy, K. F., Rick, K., Rycus, P., Mehra, M. R., Garan, A. R., Kociol, R. D., & Grandin, E. W. (2020). Hemocompatibility-Related Adverse Events and Survival on Venoarterial Extracorporeal Life Support: An ELSO Registry Analysis. JACC. Heart Failure, 8(11), 892–902. https://doi.org/10.1016/j.jchf.2020.09.004

Chicago

Chung, Mabel, Fausto R Cabezas, Jose I Nunez, Kevin F Kennedy, Katelyn Rick, Peter Rycus, Mandeep R Mehra, A Reshad Garan, Robb D Kociol, and E Wilson Grandin. 2020. “Hemocompatibility-Related Adverse Events and Survival on Venoarterial Extracorporeal Life Support: An ELSO Registry Analysis.” JACC. Heart Failure 8 (11): 892–902. doi:10.1016/j.jchf.2020.09.004.